Delivery Order SPE2DB22D2211-SPE2DB25FRWDS
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,506.12 by the Defense Logistics Agency on August 22, 2025, for the supply of Proparacaine 0.5% eye drops in 15ml quantities. The contract is firm fixed price with an ultimate completion date of August 25, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Proparacaine 0.5% eye drops in 15ml quantities. This order, valued at $1,458.94, represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Proparacaine 0.5% eye drops in 15ml quantities. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,097.76 with an ultimate completion date of September 18, 2025. The contract was awarded on September 17, 2025, and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award carries...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,481.14 to AmerisourceBergen Drug Corp for the supply of Proparacaine 0.5% eye drops in 15ml quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 5, 2025. The award was issued on August 4, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,181.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Proparacaine 0.5% eye drops (15 mL) on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $8,188.38 to AmerisourceBergen Drug Corp for the supply of 4565391207 PROPARACAINE 0.5% EYE DROPS 15ML. This contract has an ultimate completion date of August 9, 2024 and is a Firm Fixed Price contract. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical medical supplies to support military treatment facilities and other federal healthcare providers. The contract is not associated with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $2,001.80 firm fixed-price delivery order is for the provision of 4564559601 - Proparacaine 0.5% Eye Drops 15ML. The contract has an ultimate completion date of May 10, 2024. AmerisourceBergen Drug Corporation is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,019.16 Firm Fixed Price Delivery Order is for the supply of 4564339906 - Proparacaine 0.5% Eye Drops, 15ML. This contract has no set-aside designation and is for the ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Proparacaine 0.5% eye drops. The $1,902.71 fixed-price delivery order has a completion date of November 14, 2023. The contract is not designated as a set-aside award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Proparacaine 0.5% eye drops. The order has a ceiling value of $1,061.28 and is a firm fixed price contract with a completion date of July 3, 2024. The contract does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at up to...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRWDSDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,342.44 delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Proparacaine 0.5% eye drops in 15ml quantities. This is a firm fixed-price contract with an ultimate completion date of April 30, 2025, and represents a non-set-aside award made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. As the prime contractor under the SPE2DX IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support defense healthcare operations globally. The broader contract vehicle enables AmerisourceBergen to service customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a key provider within DLA's Pharmaceutical Prime Vendor program infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/29/25 |